Guselkumab: widened action in psoriatic disease
Clinics (Sao Paulo)
.
2021 May 5:76:e2629.
doi: 10.6061/clinics/2021/e2629.
eCollection 2021.
Authors
Marcelo Arnone
1
,
André Vicente Esteves de Carvalho
2
,
Lincoln Zambaldi Fabricio
3
,
Ricardo Romiti
1
Affiliations
1
Departamento de Dermatologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
2
Hospital Moinhos de Vento, Porto Alegre, RS, BR.
3
Servico de Dermatologia, Faculdade Evangelica Mackenzie do Parana, Curitiba, PR, BR.
PMID:
33978074
PMCID:
PMC8075108
DOI:
10.6061/clinics/2021/e2629
No abstract available
Publication types
Editorial
MeSH terms
Antibodies, Monoclonal, Humanized*
Double-Blind Method
Humans
Psoriasis* / drug therapy
Severity of Illness Index
Substances
Antibodies, Monoclonal, Humanized
guselkumab